Measurment of GFR by Nasal Sensors

This study has been completed.
Sponsor:
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01274169
First received: January 10, 2011
Last updated: NA
Last verified: February 2008
History: No changes posted
  Purpose

to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology


Condition
Measure GFR by Nasal Sensor

Study Type: Observational

Further study details as provided by Rambam Health Care Campus:

Study Start Date: March 2008
Estimated Study Completion Date: March 2010
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

volunteers subjects with different stages of CKD

Criteria

Inclusion Criteria:

adults between 18-70 yrs

Exclusion Criteria:

subject under 18

  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Ministry of health israel
ClinicalTrials.gov Identifier: NCT01274169     History of Changes
Other Study ID Numbers: NANOCTIL
Study First Received: January 10, 2011
Last Updated: January 10, 2011
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on April 17, 2014